In a lung adenocarcinoma model, B4GALT1 knockdown enhanced CD8+ T cell infiltration and sensitized tumors to anti-PD-1 therapy, suggesting that 1105486 may have additional benefits in combination with immunotherapy. This evidence concerns the gene CD8A and lung adenocarcinoma.